CHIRON CAPITAL MANAGEMENT, LLC - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 145 filers reported holding AURINIA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.53 and the average weighting 0.2%.

Quarter-by-quarter ownership
CHIRON CAPITAL MANAGEMENT, LLC ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$233,000
-22.1%
10,200
-24.4%
0.17%
-22.9%
Q3 2021$299,000
+95.4%
13,500
+14.4%
0.22%
+71.7%
Q2 2021$153,000
+6.2%
11,800
+6.2%
0.13%
+4.1%
Q1 2021$144,000
+0.7%
11,108
+14.5%
0.12%
+6.1%
Q3 2020$143,0009,7000.12%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 503,248$6,535,00010.30%
Prosight Management, LP 360,834$4,685,0003.84%
Healthcare Value Capital, LLC 100,000$1,299,0002.89%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,748,208$22,700,0002.32%
DG Capital Management, LLC 591,154$7,676,0001.83%
NEA Management Company, LLC 5,172,683$67,193,0001.51%
Altium Capital Management LP 408,908$5,310,0001.47%
IRONWOOD INVESTMENT MANAGEMENT LLC 170,316$2,212,0001.17%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 298,500$3,875,0001.02%
KNOTT DAVID M 154,840$2,011,0000.86%
View complete list of AURINIA PHARMACEUTICALS INC shareholders